The app facilitates better, more timely communication between all involved in a transplant event.
Photo/Thumb have been modified. Courtesy of Shutterstock / crystal light.
The National Institutes of Health (NIH) today awarded health IT startup OmniLife a $1.5 million Small Business Innovation Research Phase II grant for its organ transplant mobile health app.
OmniLife, formerly known as HealthTech Solutions, will use the money to support research and development for its proprietary software which aims to make organ transplant communication more efficient and effective.
Traditionally, organ transplant communication processes rely on outdated and non-secure forms of communication. OmniLife’s technology provides a solution called TXP Chat to bridge the gap. The platform is HIPAA-compliant and connects coordinators and clinicians in real time to facilitate better communication during the transplant process, OmniLife said.
“Our goal is to ensure that each transplant happens seamlessly without high volumes of administrative work for transplant clinicians, such as phone calls, voice mail and faxes,” said Dalton Shaull, CEO and co-founder of OmniLife. “We are breaking down communication silos and giving transplant providers all the information they need in one place so that they can focus on their patients.”
The NIH Small Business Innovation Research program encourages small business to engage in federal research and research and development. The awards-based program helps small businesses and startups explore their technological potential and adds incentive to profit from commercialization.
The program is traditionally competitive, with fewer than a 45% acceptance rating.
“This follow-on funding from the National Institutes of Health validates the problem we are working to solve and increases the impact our technology can have on the transplant community,” Shaull said.
Get the best insights in digital health directly to your inbox.